Current Edition

Volume 15 Issue 2

Serving the 0.05% of Patients Living with a Rare Disease

Increasing adoption of digital trials and data-driven commercial strategies has laid the foundations for improved pinpointing of treatments and speedier diagnoses. ...
Continue Reading →
News

With UK Pharma facing Brexit headwinds, could UK Gov't defeat help industry by leading to a “softer” Brexit? asks GlobalData

The UK Government’s narrow defeat (Wednesday 13th November) on amendment seven of the European Union withdrawal bill, demanding that Parliament have a binding vote ...
Continue Reading →